Medical Research Finder

Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

© 2026 meRfi®

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

AuthorsReferences (Sources)

meRfi® AI Chat

Adverse Events / Safety & Radiation / Radiotherapy (RT)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

Register for a free trial

Navigation

Contents

Currently, more than half of the people diagnosed with cancer need radiotherapy as a standard treatment option. However, throughout the treatment, patients frequently experience a range of side effects or injuries. These can include conditions such as radiation-induced enteritis, mucositis, and damage to the blood cells. Such side effects significantly impact the quality of life for patients and also restrict the clinical use and success of radiotherapy.
Hauer-Jensen et al. 2014 Nat Rev Gastroenterol Hepatol 11(8): 470-479
Citrin 2017 N Engl J Med 377(11): 1065-1075

Fatigue an…

References (Sources)

Gut Microbial Dysbiosis May Predict Diarrhea and Fatigue in Patients Undergoing Pelvic Cancer Radiotherapy: A Pilot Study
Wang et al. 2015a PLoS ONE 10: e0126312
Potential utility of peptides against damage induced by ionizing radiation
Shaghaghi et al. 2021 Future Oncology 17: 1219–1235
Review
Radiation enteropathy–pathogenesis, treatment and prevention
Hauer-Jensen et al. 2014 Nat Rev Gastroenterol Hepatol 11(8): 470-479
Review
Recent developments in radiotherapy
Citrin 2017 N Engl J Med 377(11): 1065-1075
Review
Safety and Antitumor Activity of the Anti-Programmed Death-1 Antibody Pembrolizumab in Patients With Advanced Esophageal Carcinoma
Doi et al. 2018
Systematic review: the role of the gut microbiota in chemotherapy- or radiation-induced gastrointestinal mucositis - current evidence and potential clinical applications
Touchefeu et al. 2014 Aliment Pharmacol Ther 40: 409-421
Review
Utility of polaprezinc in reducing toxicities during radiotherapy: a literature review
Doi et al. 2018a Future Oncology 14(9):
Review

AI Chat

7/1/2026

Chat with our artificial intelligence: